Tumor subtypes in our population were distributed as follows: 13.5% luminal A tumors, 27.8% luminal B/Her2 negative, 19.8% luminal B/Her2 positive, 21.5% TN, and 16% Her2-enriched (Table 1). Here, ERBB2 is linked to neoplasm.